Coenzyme A

From Citizendium, the Citizens' Compendium
Jump to: navigation, search
This article is basically copied from an external source and has not been approved.
Main Article
Talk
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and not meant to be cited; by editing it you can help to improve it towards a future approved, citable version. These unapproved articles are subject to a disclaimer.
The content on this page originated on Wikipedia and is yet to be significantly improved. Contributors are invited to replace and add material to make this an original article.

Coenzyme A (CoA, CoA-SH, or HS-CoA) is a coenzyme, notable for its role in the synthesis and oxidization of fatty acids, and the oxidation of pyruvate in the citric acid cycle. It is synthesized from β-mercaptoethylamine, panthothenate and adenosine triphosphate.

Function

The main function of coenzyme A is to carry acyl groups (such as the acetyl group) or thioesters. A molecule of coenzyme A carrying an acetyl group is also referred to as acetyl-CoA. It is sometimes referred to as 'CoA-SH' or 'HS-CoA' because its reactivity is due to a thiol group, -SH.

Acetyl-CoA is an important molecule itself. It is the precursor to 3-hydroxy-3-methylglutaryl CoA (HMG CoA), which is a key intermediate in cholesterol and ketogenesis. It is also an acetyl donor to choline to produce acetylcholine, in a reaction catalysed by choline acetyltransferase. Its main task is conveying the carbon atoms within the acetyl group to the citric acid cycle to be oxidized for energy production.

Pyruvate Dehydrogenase Reaction

The conversion of pyruvate into acetyl-CoA is catalyzed by an enzyme-complex called pyruvate dehydrogenase. The enzyme consists of 60 subunits: 24 pyruvate dehydrogenase, 24 dihydrolipoyl transacetylase, and 12 dihydrolipoyl dehydrogenase (commonly denoted E1, E2, and E3). The pyruvate dehydrogenase subunits contain the coenzyme TPP (thiamin pyrophosphate), dihydrolipoyl transacetylase subunits carry lipoate and coenzyme A, and the dihydrolipoyl dehydrogenase subunits contain the electron-transferring coenzymes FAD and NAD+.
The reaction of this complex follows three steps.

Initially, pyruvate is bound by pyruvate dehydrogenase subunits and attacked at C2 by the zwitterionic form (negative charge about C2 of the thiazolium ring) of thiamin pyrophosphate, also bound by the enzyme. This tetrahedral intermediate undergoes decarboxylation resulting in an acyl anion equivalent (see cyanohydrin or aldehyde-dithiane umpoloung chemistry, as well as benzoin condensation). This anion attacks the S1 of the oxidized lipoate species in an Sn2-like mechanism that displaces the S2 thiol as a sulfide or sulfhydryl moiety.

Subsequent breakdown of the thiazole-hemithioacetal species ejects the TPP cofactor and generates an S1 thioester about the lipoate moiety. At this point, the lipoate-thioester functionality is translocated into the lipoate transacetylase active site, where it undergoes a transacylation with coenzyme A, generating dihydrolipoate and acetyl CoA which subsequently enters the citric acid cycle. The dihydrolipoate moiety then migrates to the dihydrolipoyl dehydrogenase active site where it undergoes FAD-mediated oxidation (identical in chemistry to disulfide isomerase) which returns lipoate to its resting state and generates FADH2, which is further oxidized by the bound nicotinamide cofactor producing NADH2 and regenerated flavin.

Metabolism

Coenzyme A is central to the balance between carbohydrate metabolism and fat metabolism. Normally, acetyl-CoA from fatty acid metabolism feeds into the citric acid cycle, contributing to the cell's energy supply. In the liver, when levels of circulating fatty acids are high, the production of acetyl-CoA from fat breakdown exceeds the cellular energy requirements. To make use of the energy available from the excess acetyl-CoA, ketone bodies are produced which can then circulate in the blood.

In some circumstances this can lead to an excess of ketone bodies in the blood, a condition known as ketoacidosis. This can occur in diabetes, starvation or in people following low-carbohydrate diets, all of which can cause fats to be metabolised as a major source of energy.

See also

References